Overactive bladder (OAB) has become more common among men in the United States. From 2015 to 2020, about 14.5 percent of men experienced OAB, marking a significant increase compared to previous years. This information was shared in a study published online on July 15 in Scientific Reports.
Overactive bladder
Overactive bladder (OAB) is a urological condition defined by a set of symptoms: “urgency, with or without urge incontinence, usually with frequency and nocturia”.
COVID-19 Vaccine Side Effects on Bladder Health in Young Adults Revealed
COVID-19 vaccination has been found to cause some side effects on the lower urinary tract and overactive bladder in younger adults. A study published online on June 24 in Frontiers in Medicine reported these findings.
Marta de-la-Plaza-San-Frutos, from Universidad Europea de Madrid in Spain, and her team examined potential side effects of COVID-19 vaccination on the urinary tract. A total of 1,563 individuals (74.7 percent women and 27.3 percent men), aged 18 to 45 years, completed an online survey.
Allergan agreed to pay $600 million to US Government
Allergan Resolves United States Government Investigation of Past Sales and Marketing Practices Relating to Certain Therapeutic Uses of BOTOX(R) – Allergan, Inc. (NYSE: AGN) announced that it has reached a resolution with the United States Department of Justice (DOJ) regarding the previously reported Government investigation into Allergan’s past U.S. sales and marketing practices relating to certain therapeutic uses of BOTOX(R) (onabotulinumtoxinA).
Botox can improve overactive bladder symptoms
Botox injections can significantly improve quality of life for people with overactive bladders – Botox is well known for its cosmetic uses, but researchers have now found that it can also significantly improve people’s quality of life if they suffer from another problem that increases with age, an overactive bladder (OAB).
Clinical trials overseas raises quality control issues
Questions of ethics and quality cloud globalization of clinical trials – Top-tier U.S.-based pharmaceutical companies are moving their clinical trials overseas at warp speed, raising questions about ethics, quality control, and even the scientific value of their findings for people back in the U.S.
1 in 3 women has pelvic floor disorder, overactive bladder or incontinence
Kaiser Permanente study found that one-third of women suffer from one or more pelvic floor disorders, which include symptoms such as the frequent urge to urinate, dropped pelvic organs, and incontinence. – A new study by Kaiser Permanente found that one-third of women suffer from one or more pelvic floor disorders, which include symptoms such as the frequent urge to urinate, dropped pelvic organs, and incontinence. The study, which consists of the broadest age range of participants to date, of which 80 percent of the 4,000 women studied had given birth.